Want to see COGT full AI Analyst Report?
Cogent Biosciences (COGT) Income Statement
Cogent Biosciences Income Statement
Last quarter (Q2 2026), Cogent Biosciences's total revenue was $0.00. In Q2, Cogent Biosciences's net income was $-96.41M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -4.62M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 328.74M | $ 275.94M | $ 208.13M | $ 147.84M | $ 75.55M | |
| Depreciation and Amortization | $ 4.58M | $ 4.35M | $ 3.59M | $ 5.88M | $ 147.00K |
| $ -321.29M | $ -251.51M | $ -188.82M | $ -130.37M | $ -72.13M | |
| $ -333.36M | $ -275.94M | $ -208.13M | $ -147.84M | $ -75.55M | |
| $ 4.43M | $ 20.08M | $ 15.72M | $ 7.60M | $ 3.28M | |
| $ -328.94M | $ -255.86M | $ -192.41M | $ -140.24M | $ -72.27M | |
| $ -328.94M | $ -255.86M | $ -192.41M | $ -140.24M | $ -72.27M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.04 | $ -2.32 | $ -2.42 | $ -2.26 | $ -1.85 |
| Diluted EPS | $ -2.04 | $ -2.32 | $ -2.42 | $ -2.26 | $ -1.85 |
| Weighted Average Shares Outstanding | 160.98M | 110.46M | 79.66M | 58.74M | 38.73M |
| Weighted Average Shares Outstanding (Diluted) | 160.98M | 110.46M | 79.66M | 58.74M | 38.73M |
Currency in USD
